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Introduction
Immunoglobulin subclass 4 (IgG4)-associated diseases are an increasingly recognized group of autoimmune diseases, 1, 2 which are characterized by sclerosis and lymphoplasmocytic infiltration of affected organs with IgG 4-positive cells. [2] [3] [4] [5] The disease can affect the pancreas, biliary tract, salivary glands, retroperitoneum, lymph nodes, kidney, lungs or the prostate. 6, 7 In the gastrointestinal tract, autoimmune pancreatitis (AIP) and IgG 4-associated cholangitis (IAC) are considered the most common manifestations. 8 The prevalence of AIP ranges from 4% to 8% among patients with pancreatitis in different study cohorts. 9 Common differential diagnoses of AIP and IAC include chronic pancreatitis, pancreatic cancer and primary sclerosing cholangitis. 1, 10, 11 Male predominance and a mean age of 60 Ϯ 10 years were consistently reported. 5, 6, 12, 13 Clinicopathological and radiological features include jaundice, abdominal pain, and diabetes mellitus, extra and
The preliminary results of this study were presented as a poster at the AASLD (American Association for the Study of Liver Diseases) liver meeting 2010 in Boston. DOI:10.1111/j.1477-2574.2011.00413.x intrahepatic biliary strictures, pancreatic duct encasement and a sausage shape of the pancreas on abdominal magnetic resonance imaging (MRI) or computed tomography (CT). 1, 5, 6, 13 Studies on IgG4-related diseases were predominantly carried out in Asian countries, [14] [15] [16] the United States of America 5 and Europe, 9, 17 where different diagnostic criteria for AIP have been proposed by several societies. The Japanese and Korean criteria were established in 2006 and 2007, respectively. 15, 16 The HISORt criteria (Histology, Imaging, Serology, Other organ involvement, Response to therapy) were proposed by Chari et al. in 2006. 5 The typical histological finding of IgG4-related diseases is infiltration of affected organs with IgG 4-positive plasma cells. 5, 15, 16 Imaging studies in patients with IAC or AIP show irregular narrowing of the bile ducts or the pancreatic duct by endoscopic retrograde cholangiopancreaticography (ERCP), and enlargement of affected organs or pseudotumour formation. Elevated serum IgG 4 and autoantibodies (ANA and RF) are commonly found in serological studies. 1, 5, 9, 15, 16 More specific antibodies directed against carbonic anhydrase II, SPINK1 or trypsinogen have been identified. 18 The performance of total IgG4 serum concentrations for the diagnosis of IgG 4-related diseases has been evaluated in different studies. A cut-off for IgG 4 elevation was suggested at Ն135 mg/dl by Hamano et al. in 2001 with a sensitivity of 95% and a specificity of 97%. 4 The Mayo Clinic group reported a specificity and a sensitivity of 93% and 76%, respectively, at a cut-off level of >140 mg/dl. In patients with IgG 4 concentrations >280 mg/dl, a sensitivity of 53% and a specificity of 99% was found. 5 Based on these findings, the IgG4 serum concentration has been proposed as a non-invasive parameter for the diagnosis of IgG 4-related disease and is included in the HISORt criteria.
The aim of the present study was to evaluate the sensitivity and specificity of a serum IgG 4 concentration in an unselected liver and pancreas clinic population.
Patients and methods
From January 2009 to May 2010, serum immunoglobulin subclasses were prospectively determined in all patients referred to the unit of gastroenterology and hepatology at the Medical University Innsbruck, Austria. To record clinical diagnoses, patients' charts were carefully reviewed and a diagnosis of AIP and AIC was made according to the HISORt and ASIAN criteria. IgG 4 concentrations were determined in patients' sera using the immunoglobulin subclass assay from Siemens N IGG4 (formerly Dade Behring, Marburg, Germany) on a Behring Nephelometryplatform (BN II). The interassay coefficients of variation were 3.7% at 0.195 g/l, 2.4% at 0.507 g/l and 3.5% at 0.729 g/l, respectively.
Statistical analysis
Results are shown as absolute numbers and medians (with range). Analysis of variables with a non-normal distribution was carried out using Mann-Whitney U-tests and means of normally distributed variables were compared with t-tests. Exact P-values for fre-quency tables were calculated using the chi-square test and association of variables was assessed by Pearson's correlation. A two-sided P-value of less than 0.05 was considered statistically significant. The diagnostic performance of IgG 4 was calculated by receiver-operating characteristic (ROC) analyses with the areaunder-the-curve (AUC) statistic and a 95% confidence interval (CI). The statistical analysis of the data was performed in SPSS version 18.0 (SPSS, Chicago, IL, USA).
Results
The diagnostic performance of IgG4 was determined in 1412 consecutive patients referred to our unit from January 2009 to May 2010. Baseline demographic characteristics are shown in Table 1 . A diagnosis of pancreatitis or cholangitis was made in 192 patients (13%). Male gender was predominant in both diseases and median age did not significantly differ between these two groups.
The median IgG 4 concentration in patients with pancreatitis was 45.7 mg/dl (range: 1.8-1330 mg/dl), in patients with cholangitis 70.0 mg/dl (range: 6.6-669.0 mg/dl) and 47.5 mg/dl (range: 0.2-1230.0 mg/dl) in the remaining patient cohort. These differences did not reach statistical significance. An IgG 4 concentration of Ն135 mg/dl was found in 210 of 1412 patients (14.9%).
Review of patient charts in the entire cohort identified 22 patients with the clinical diagnosis AIP or IAC. Of these, 15 fulfilled HISORt and Asian criteria for the diagnosis of IgG 4-related diseases. A median IgG 4 concentration in patients with IAC according to HISORt was 240 mg/dl (range: 101-669) and 94 mg/dl (3.5-1330) in patients with AIP compared with 47.1 mg/dl in the remaining cohort (P < 0.001).
The prevalence of AIP and/or IAC was 1.1% in the entire cohort (15 of 1412) and 7.8% in the subgroup of 192 patients with pancreatitis or cholangitis. In all, 80% of patients with AIP or IAC (12 of 15) had an IgG 4 concentration above 135 mg/dl as compared with 14% of patients without AIP or IAC (198 of 1397). This results in a positive predictive value of 5.7%.
At a cut-off of Ն135 mg/dl, the sensitivity of IgG 4 for the diagnosis of AIP or IAC was 80% (95% CI: 55% to 93%) and the specificity was 86% [95% confidence interval (CI): 84% to 88%; Table 2 ]. The area under the ROC curve was 0.837 (95% CI: 0.713 to 0.960; Fig. 1 ) and the optimal cut-off in our patient cohort was Ն145 mg/dl with a sensitivity of 80% and a specificity of 88%.
To identify potential causes of elevated serum IgG 4 concentrations, the main diagnoses were recorded in all 210 patients with a An increased serum IgG 4 concentration in liver cirrhosis patients could be attributed to hypergammaglobulinaemia which is a common finding in patients with portal hypertension. Correlation analysis showed that IgG 4 was weakly correlated with total immunoglobulin in the entire cohort (r = 0.4, P < 0.001). However, the area under the ROC curve of the IgG 4/total IgG ratio (AUC: 0.838; 95% CI: 0.713 to 0.962) was not different from that of IgG 4, indicating that the diagnostic performance of IgG4 cannot be improved by including total IgG.
Discussion
Autoimmune pancreatitis and IAC are typically associated with elevated serum IgG 4 concentrations, where its positive and negative predictive values in a selected patient population are 36% and 99% at a threshold of 140 mg/dl. 10 A general gastroenterology and hepatology clinic population was investigated in the present study where a reasonable sensitivity (80%) and specificity (86%) of IgG 4 was found ( Table 2) .
A surprising result of the present study is the frequent increase in serum IgG 4 in patients with other underlying diseases, especially in patients with end-stage liver disease. The high number of false-positive results translates to a positive predictive value of only 6% for a cut-off of Ն135 mg/dl. Whether liver cirrhosis is a consequence of IAC in these patients or increased serum IgG 4 concentrations result from impaired metabolic function has to be established. Nevertheless, liver cirrhosis should be considered as a differential diagnosis in patients with unexplained IgG 4 elevation.
The optimal cut-off was 145 mg/dl in the present study, which is close to the cut-off of 140 mg/dl suggested in the HISORt criteria. 5 The varying cut-offs suggested by different groups may be a result of different assays used for measurement of serum IgG 4: Nephelometric assays were used in the present study and by the Mayo group, 5 whereas an enzyme-linked immunosorbent assay and a single radial immunodiffusion assay was used by Hamano et al. 4 As previously shown, even at a threshold of >200 mg/dl, pancreatic cancer or cholangiocarcinoma cannot be excluded 10 which illustrates the necessity for a biopsy to confirm the diagnosis.
The negative predictive value of IgG 4 was 99% in a previous study 10 which was confirmed in our study. An important differential diagnosis in patients with suspected AIP and negative IgG 4 is type II AIP, whose diagnosis relies on the histological finding of granulocytic epithelial lesions and narrowing of the pancreatic duct. 18 Findings from non-invasive tests that are indicative of type II AIP are the positivity for ANA, SMA or more specific autoan- tibodies directed against carbonic anhydrase II, SPINK1 or trypsinogen. 18 Another condition where a false-negative IgG4 test result could be expected is previous treatment with steroids. 19 In conclusion, AIP and IAC are emerging entities, whose diagnosis relies on clinical, radiological, biochemical and histological criteria. In clinical practice, malignant diseases of the biliary tree and pancreas are important differential diagnoses. Clear diagnostic criteria, ideally based on non-invasive tests, are required to avoid unnecessary surgery and to discriminate inflammatory from neoplastic diseases. Practical limitations of HISORt criteria are that invasive procedures are required to obtain histology and that the response to steroids can only be assessed after the presumed diagnosis has been made.
The present study confirms that the proposed threshold for IgG 4 is in the range of Ն135 mg/dl and shows that in spite of its excellent negative predictive value, its positive predictive value renders it insufficient to be used as an isolated parameter. Furthermore, serum IgG 4 is not suited as a first-line screening test, owing to the low prevalence of IgG 4-related diseases and the high rate of false-positive results. Particularly liver cirrhosis is an important differential diagnosis and commonly associated with elevated IgG 4.
